Windtree Therapeutics, Inc.
Windtree Therapeutics, Inc. (WINT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · WINT · as of Jun 9, 2026
Key Statistics
Explore Windtree Therapeutics, Inc. Data
wint stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 60.0%
Competitors & Peers
wint competitorsWINT
AIMD
ATXI
DRMA
ELAB
GTBPStock Performance
Full HistoryAbout Windtree Therapeutics, Inc.
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical firm primarily dedicated to developing therapies for acute cardiovascular ailments, and secondarily for acute pulmonary diseases. Its …
what is windtree therapeutics, inc. · wint stock overview · windtree therapeutics, inc. company profile · who is windtree therapeutics, inc. ceo · wint OTC · windtree therapeutics, inc. headquarters · windtree therapeutics, inc. business segments
About Stock Overview & Key Data
Windtree Therapeutics, Inc. (WINT) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 7, 1995. As of the latest trading session, WINT stock price is $0.01, with a market capitalization of $482,036. The stock has returned -97.43% over the past 12 months and -52.33% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Windtree Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Windtree Therapeutics, Inc. reported revenue of — and net income of -$5.5M. For detailed data — including Windtree Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Windtree Therapeutics, Inc. (WINT) stock price is $0.01. The stock is traded on OTC under the ticker symbol WINT. The 52-week range is $0.01 – $1.86.